Outset Medical, Inc. is a healthcare company based in the United States, with a Risk Rating Score of 24.9, placing it at a medium risk level. They specialize in medical technology, specifically their innovative machine, Tablo, designed to streamline and simplify dialysis procedures. Tablo offers Renal Replacement Therapy in Hospitals, Chronic Care in Dialysis Clinics, and Home Dialysis, making healthcare more efficient and accessible. With a focus on ESG principles, Outset Medical is revolutionizing the way dialysis is administered.